Sanofi’s Enjaymo, once a jewel in its Bioverativ buyout, finally wins its FDA nod for a rare blood disorder kdunleavy Fri, 02/04/2022 – 16:56 More: Sanofi's Enjaymo, once a jewel in its Bioverativ buyout, finally wins its FDA nod for
read moreRegeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it kdunleavy Fri, 02/04/2022 – 11:00 More: Regeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it Source: fierce
read moreThe hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes fkansteiner Fri, 02/04/2022 – 10:58 More: The hits keep coming: Biogen's Aduhelm marketing, approval under fire in new FTC and SEC probes Source: fierce
read moreBristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms esagonowsky Fri, 02/04/2022 – 10:34 More: Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms Source: fierce
read moreUPDATED: Sanofi’s flu shots took a back seat to COVID-19 boosters late last year, and major job cuts still loom fkansteiner Fri, 02/04/2022 – 09:47 More: UPDATED: Sanofi's flu shots took a back seat to COVID-19 boosters late last year,
read moreEli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending crown badams Fri, 02/04/2022 – 08:17 More: Eli Lilly’s Trulicity dethrones Dupixent, taking January's TV ad spending crown Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals